Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody
Authors:
- 17 April 2018
- journal article
- research article
- Published by Springer Nature in The AAPS Journal
- Vol. 20 (3) , 63
Abstract
A prominent example of human therapeutic protein-drug interaction (TP-DI) is between methotrexate (MTX) and anti-TNFα mAbs. One plausible mechanism for this TP-DI is through the pharmacodynamic...Keywords
This publication has 40 references indexed in Scilit:
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritisNature Reviews Rheumatology, 2013
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent mannerAnnals of the Rheumatic Diseases, 2012
- ADME of Biologics—What Have We Learned from Small Molecules?The AAPS Journal, 2012
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and EfficacyThe AAPS Journal, 2012
- Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitisBritish Journal of Clinical Pharmacology, 2011
- How Current Understanding of Clearance Mechanisms and Pharmacodynamics of Therapeutic Proteins Can Be Applied for Evaluation of Their Drug-Drug Interaction PotentialDrug Metabolism and Disposition, 2011
- Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative studyArthritis Research & Therapy, 2011
- AAPS Workshop Report: Strategies to Address Therapeutic Protein–Drug Interactions during Clinical DevelopmentThe AAPS Journal, 2011
- Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet® biolayer interferometryJournal of Pharmaceutical and Biomedical Analysis, 2011
- Formation, Distribution, and Elimination of Infliximab and Anti-Infliximab Immune Complexes in Cynomolgus MonkeysThe Journal of Pharmacology and Experimental Therapeutics, 2005